US Patent 11085079 Universal Sanger sequencing from next-gen sequencing amplicons

Patent 11085079 was granted and assigned to Quest Diagnostics on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Quest Diagnostics

Current Assignee

Quest Diagnostics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11085079

Date of Patent

August 10, 2021

Patent Application Number

20181026

Date Filed

October 26, 2018

Patent Citations Received

‌

US Patent 11959838 Representative diagnostics

Patent abstract

Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11085079 Universal Sanger sequencing from next-gen sequencing amplicons

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API